AT275737B - Verfahren zur Herstellung von stabilisierten pharmazeutischen Lösungen von α-Liponsäure - Google Patents

Verfahren zur Herstellung von stabilisierten pharmazeutischen Lösungen von α-Liponsäure

Info

Publication number
AT275737B
AT275737B AT1145467A AT1145467A AT275737B AT 275737 B AT275737 B AT 275737B AT 1145467 A AT1145467 A AT 1145467A AT 1145467 A AT1145467 A AT 1145467A AT 275737 B AT275737 B AT 275737B
Authority
AT
Austria
Prior art keywords
preparation
lipoic acid
pharmaceutical solutions
stabilized pharmaceutical
stabilized
Prior art date
Application number
AT1145467A
Other languages
English (en)
Original Assignee
Pfrimmer & Co J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfrimmer & Co J filed Critical Pfrimmer & Co J
Application granted granted Critical
Publication of AT275737B publication Critical patent/AT275737B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT1145467A 1967-09-25 1967-12-19 Verfahren zur Herstellung von stabilisierten pharmazeutischen Lösungen von α-Liponsäure AT275737B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1617740 1967-09-25

Publications (1)

Publication Number Publication Date
AT275737B true AT275737B (de) 1969-11-10

Family

ID=5682288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1145467A AT275737B (de) 1967-09-25 1967-12-19 Verfahren zur Herstellung von stabilisierten pharmazeutischen Lösungen von α-Liponsäure

Country Status (4)

Country Link
AT (1) AT275737B (de)
DE (1) DE1617740B1 (de)
ES (1) ES357954A1 (de)
FR (1) FR1605097A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038733T3 (es) * 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
FR2653997B1 (fr) * 1989-11-09 1995-01-20 Asta Pharma Ag Medicaments contenant comme sunstances actives des acides carboxyliques soufres, leur preparation et leur utilisation pour lutter contre les retrovirus.
DE102004050353A1 (de) * 2004-10-15 2006-04-20 Basf Ag Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1205972B (de) * 1963-08-20 1965-12-02 Merck Ag E Verfahren zur Herstellung eines Liponsaeure-derivates

Also Published As

Publication number Publication date
ES357954A1 (es) 1970-04-01
FR1605097A (en) 1973-01-12
DE1617740B1 (de) 1971-11-04

Similar Documents

Publication Publication Date Title
CH518951A (de) Verfahren zur Herstellung von 2-Amino-adenosinderivaten
CH507248A (de) Verfahren zur Herstellung von D-6-Methylergolin(I)ylessigsäure
AT286314B (de) Verfahren zur Herstellung von 2,2-Dichlor-vinyl-phosphorsäureesteramiden
CH498104A (de) Verfahren zur Herstellung von Carbamidsäurefluoriden
CH526538A (de) Verfahren zur Herstellung von Aminophenylessigsäure-Derivaten
CH505854A (de) Verfahren zur Herstellung von pharmazeutisch wirksamen Verbindungen der 7-Acylamino-Cephalosporansäure
CH517690A (de) Verfahren zur Herstellung von a-Methyl-2-naphthyl-essigsäurealkylestern
CH504473A (de) Verfahren zur Herstellung von Cephalosporansäurederivaten
CH496010A (de) Verfahren zur Herstellung von d-Lysergsäureamiden
CH492669A (de) Verfahren zur Herstellung von p-Hydroxybenzoesäure
CH501601A (de) Verfahren zur Herstellung von 4,4'-Diphenyldisulfonsäure
CH500935A (de) Verfahren zur Herstellung von Phenylsalicylsäure-Verbindungen
AT299447B (de) Verfahren zur Herstellung von 7-Aminocephalosporansäure
CH500232A (de) Verfahren zur Herstellung von Alkylthionophosphonsäuredichloriden
AT292014B (de) Verfahren zur Herstellung von Organozinnmerkaptosäureestern
AT284143B (de) Verfahren zur Herstellung von neuen Dithiocarbaminsäurederivaten
CH499483A (de) Verfahren zur Herstellung von Phenoxyphthalsäureester
CH508589A (de) Verfahren zur Herstellung von B-Aminocarbonsäurederivaten
CH510059A (de) Verfahren zur Herstellung von Amidothionophosphorsäurephenylestern
CH503689A (de) Verfahren zur Herstellung von Phenyl-benzoesäure-Verbindungen
AT286960B (de) Verfahren zur Herstellung der d-trans-Pyrethrinsäure
CH501555A (de) Verfahren zur Herstellung von Hydroxylamin-O-sulfosäure
CH485641A (de) Verfahren zur Herstellung von Acetessigsäureestern
CH497395A (de) Verfahren zur Herstellung von Sulfensäurederivaten
CH481927A (de) Verfahren zur Herstellung von 2,4-Dichlor-pyrimidin-5-carbonsäurechlorid